The effects of cannabinoid CB1, CB2 and vanilloid TRPV1 receptor antagonists on cocaine addictive behavior in rats

Brain Research

Volumn 1444, Issue , 2012, Pages 45-54

  Adamczyk, Przemysław ^a   Miszkiel, Joanna ^a   McCreary, Andrew C ^b,c   Filip, Małgorzata ^a   Papp, Mariusz ^a   Przegaliński, Edmund ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b Abbott   (Netherlands)

^c CHARLES RIVER LABORATORIES   (United States)

Author keywords

Cannabinoid CB1 receptor; Cannabinoid CB2 receptor; Cocaine self administration; Endocannabinoid system; Rat; Reinstatement; Vanilloid TRPV1 receptor

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 4 CHLORO N (3 METHOXYPHENYL)CINNAMAMIDE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; COCAINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DISEASE MODEL; DRUG SELF ADMINISTRATION; EVALUATION; FOOD; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANILIDES; ANIMALS; BEHAVIOR, ADDICTIVE; BORNANES; CINNAMATES; COCAINE-RELATED DISORDERS; CONDITIONING, OPERANT; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTINCTION, PSYCHOLOGICAL; FOOD; MALE; MOTOR ACTIVITY; PIPERIDINES; PYRAZOLES; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; REINFORCEMENT (PSYCHOLOGY); REINFORCEMENT SCHEDULE; SELF ADMINISTRATION; TRPV CATION CHANNELS;

ANIMALIA; RATTUS;

EID: 84857790066     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2012.01.030     Document Type: Article

References (71)

1. P. Adamczyk, A.C. McCreary, E. Przegaliński, P. Mierzejewski, P. Bienkowski, and M. Filip The effects of fatty acid amide hydrolase inhibitors on maintenance of cocaine and food self-administration and on reinstatement of cocaine-seeking and food-taking behavior in rats J. Physiol. Pharmacol. 60 3 2009 119 125
2. J.C. Arnold The role of endocannabinoid transmission in cocaine addiction Pharmacol. Biochem. Behav. 81 2 2005 396 406 (Pubitemid 40812406)
3. M. Arnone, J. Maruani, F. Chaperon, M.H. Thiébot, M. Poncelet, P. Soubrié, and G. Le Fur Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors Psychopharmacology (Berl) 132 1 1997 104 106 (Pubitemid 27303746)
4. D. Baker, G. Pryce, G. Giovannoni, and A.J. Thompson The therapeutic potential of cannabis Lancet Neurol. 2 5 2003 291 298 (Pubitemid 38368569)
5. B.S. Basavarajappa Critical enzymes involved in endocannabinoid metabolism Protein Pept. Lett. 14 3 2007 237 246 (Pubitemid 46376854)
6. T. Bisogno, F. Berrendero, G. Ambrosino, M. Cebeira, J.A. Ramos, J.J. Fernandinez-Ruiz, and V. Di Marzo Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function Biochem. Biophys. Res. Commun. 256 1999 377 380 (Pubitemid 29298893)
7. G. Colombo, R. Agabio, G. Diaz, C. Lobina, R. Reali, and G.L. Gessa Appetite suppression and weight loss after the cannabinoid antagonist SR 141716 Life Sci. 63 8 1998 PL113 PL117
8. K.P. Cosgrove Imaging receptor changes in human drug abusers Curr. Top. Behav. Neurosci. 3 2010 199 217
9. G. Cossu, C. Ledent, L. Fattore, A. Imperato, G.A. Böhme, M. Parmentier, and W. Fratta Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse Behav. Brain Res. 118 1 2001 61 65 (Pubitemid 32037114)
10. M.L. Cox, V.L. Haller, and S.P. Welch The antinociceptive effect of Δ9-tetrahydrocannabinol in the arthritic rat involves the CB2 cannabinoid receptor Eur. J. Pharmacol. 570 2007 50 56 (Pubitemid 47247676)
11. T.J. De Vries, Y. Shaham, J.R. Homberg, H. Crombag, K. Schuurman, J. Dieben, L.J. Vanderschuren, and A.N. Schoffelmeer A cannabinoid mechanism in relapse to cocaine seeking Nat. Med. 7 10 2001 1151 1154 (Pubitemid 33010025)
12. V. Di Marzo, and M. Maccarrone FAAH and anandamide: is 2-AG really the odd one out? Trends Pharmacol. Sci. 29 5 2008 229 233
13. M.R. Elphick, and M. Egertová The neurobiology and evolution of cannabinoid signalling Philos. Trans. R. Soc. Lond. B Biol. Sci. 356 1407 2001 381 408 (Pubitemid 32324674)
14. L. Fattore, M.C. Martellotta, G. Cossu, M.S. Mascia, and W. Fratta CB1 cannabinoid receptor agonist WIN 55,212-2 decreases intravenous cocaine self-administration in rats Behav. Brain Res. 104 1-2 1999 141 146 (Pubitemid 29421642)
15. +-evoked (3H)-dopamine efflux from rat striatal synaptosomes: a novel action of cocaine J. Neural Transm. 117 5 2010 593 597
16. M. Filip, A. Gołda, M. Zaniewska, A.C. McCreary, E. Nowak, W. Kolasiewicz, and E. Przegaliński Involvement of cannabinoid CB1 receptors in drug addiction: effects of rimonabant on behavioral responses induced by cocaine Pharmacol. Rep. 58 6 2006 806 819 (Pubitemid 46117732)
17. B. Forget, K.M. Coen, and B. Le Foll Inhibition of fatty acid amide hydrolase reduces reinstatement of nicotine seeking but not break point for nicotine self-administration-comparison with CB(1) receptor blockade Psychopharmacology (Berl) 205 4 2009 613 624
18. C.S. Freedland, J.S. Poston, and L.J. Porrino Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding Pharmacol. Biochem. Behav. 67 2 2000 265 270 (Pubitemid 32000832)
19. K. Fuxe, D. Marcellino, D. Guidolin, A.S. Woods, and L.F. Agnati Heterodimers and receptor mosaics of different types of G-protein-coupled receptors Physiology (Bethesda) 23 2008 322 332
20. H. Garavan, J. Pankiewicz, A. Bloom, J.-K. Cho, L. Sperry, T.J. Ross, B.J. Salmeron, R. Risinger, D. Kelley, and E.A. Stein Cue-induced cocaine craving: neuroanatomical specifity for drug users and drug stimuli Am. J. Psychiatry 157 2000 1789 1798
21. R.Z. Goldstein, and N.D. Volkow Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex Am. J. Psychiatry 159 2002 1642 1652
22. R.A. Goldstein, C. DesLauriers, and A.M. Burda Cocaine: history, social implications, and toxicity - a review Dis. Mon. 55 1 2009 6 38
23. G. González-Cuevas, H. Aujla, R. Martin-Fardon, J.A. López-Moreno, M. Navarro, and F. Weiss Subchronic cannabinoid agonist (WIN 55,212-2) treatment during cocaine abstinence alters subsequent cocaine seeking behavior Neuropsychopharmacology 32 11 2007 2260 2266 (Pubitemid 47587677)
24. M.J. Gunthorpe, H.K. Rami, J.C. Jerman, D. Smart, C.H. Gill, E.M. Soffin, S. Luis Hannan, S.C. Lappin, J. Egerton, G.D. Smith, A. Worby, L. Howett, D. Owen, S. Nasir, C.H. Davies, M. Thompson, P.A. Wyman, A.D. Randall, and J.B. Davis Identification and characterisation of SB-366791, a potent and selective vanilloid receptor (VR1/TRPV1) antagonist Neuropharmacology 46 1 2004 133 149 (Pubitemid 37494747)
25. L. Hanuš, A. Breuer, S. Tchilibon, S. Shiloah, D. Goldenberg, M. Horowitz, R.G. Pertwee, R.A. Ross, R. Mechoulam, and E. Fride HU-308: a specific agonist for CB2, a peripheral cannabinoid receptor PNAS 96 25 1999 14228 14233 (Pubitemid 30000633)
26. M. Herkenham, A.B. Lynn, M.R. Johnson, L.S. Melvin, B.R. de Costa, and K.C. Rice Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study J. Neurosci. 11 2 1991 563 583
27. A. Higuera-Matas, M.L. Soto-Montenegro, N. del Olmo, M. Miguéns, I. Torres, J.J. Vaquero, J. Sánchez, C. García-Lecumberri, M. Desco, and E. Ambrosio Augmented acquisition of cocaine self-administration and altered brain glucose metabolism in adult female but not male rats exposed to a cannabinoid agonist during adolescence Neuropsychopharmacology 33 4 2008 806 813 (Pubitemid 351252702)
28. A.L. Hildebrandt, D.M. Kelly-Sullivan, and S.C. Black Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice Eur. J. Pharmacol. 462 1-3 2003 125 132 (Pubitemid 36183743)
29. A.C. Howlett, C.S. Breivogel, S.R. Childers, S.A. Deadwyler, R.E. Hampson, and L.J. Porrino Cannabinoid physiology and pharmacology: 30 years of progress Neuropharmacology 47 Suppl 1 2004 345 358 (Pubitemid 39298276)
30. L. Hull, J. May, D. Farrell-Moore, and D.S. Svikis Treatment of cocaine abuse during pregnancy: translating research to clinical practice Curr. Psychiatry Rep. 12 5 2010 454 461
31. L. Jean-Gilles, B. Gran, and C.S. Constantinescu Interaction between cytokines, cannabinoids and the nervous system Immunobiology 215 8 2010 606 610
32. Z. Justinova, G. Tanda, G.H. Redhi, and S.R. Goldberg Self-administration of delta9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys Psychopharmacology (Berl) 169 2 2003 135 140 (Pubitemid 37129964)
33. Z. Justinova, M. Solinas, G. Tanda, G.H. Redhi, and S.R. Goldberg The endogenous cannabinoid anandamide and its synthetic analog R(+)-methanandamide are intravenously self-administered by squirrel monkeys J. Neurosci. 25 23 2005 5645 5650 (Pubitemid 40800656)
34. Z. Justinova, R.A. Mangieri, M. Bortolato, S.I. Chefer, A.G. Mukhin, J.R. Clapper, A.R. King, G.H. Redhi, S. Yasar, D. Piomelli, and S.R. Goldberg Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates Biol. Psychiatry 64 11 2008 930 937
35. K.M. Kampman What's new in the treatment of cocaine addiction? Curr. Psychiatry Rep. 12 5 2010 441 447
36. N.M. Kogan, and R. Mechoulam Cannabinoids in health and disease Dialogues Clin. Neurosci. 9 4 2007 413 430 (Pubitemid 351187565)
37. H.M. Lesscher, E. Hoogveld, J.P. Burbach, J.M. van Ree, and M.A. Gerrits Endogenous cannabinoids are not involved in cocaine reinforcement and development of cocaine-induced behavioural sensitization Eur. Neuropsychopharmacol. 15 1 2005 31 37 (Pubitemid 39574397)
38. A. Luchicchi, S. Lecca, S. Carta, G. Pillolla, A.L. Muntoni, S. Yasar, S.R. Goldberg, and M. Pistis Effects of fatty acid amide hydrolase inhibition on neuronal responses to nicotine, cocaine and morphine in the nucleus accumbens shell and ventral tegmental area: involvement of PPAR-alpha nuclear receptors Addict. Biol. 15 3 2010 277 288
39. M. Maćkowiak, A. Chocyk, D. Dudys, and K. Wedzony Activation of CB1 cannabinoid receptors impairs memory consolidation and hippocampal polysialylated neural cell adhesion molecule expression in contextual fear conditioning Neuroscience 158 2009 1708 1716
40. S. Maione, T. Bisogno, V. de Novellis, E. Palazzo, L. Cristino, M. Valenti, S. Petrosino, V. Guglielmotti, F. Rossi, and V. Di Marzo Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors J. Pharmacol. Exp. Ther. 316 3 2006 969 982 (Pubitemid 43345268)
41. C. Mazzola, J. Medalie, M. Scherma, L.V. Panillio, M. Solinas, G. Tanda, F. Drago, J.L. Cadet, S.R. Goldberg, and S. Yasar Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-α nuclear receptors Learn. Mem. 16 2010 332 337
42. R. Mechoulam, E. Fride, and V. Di Marzo Endocannabinoids Eur. J Pharmacol. 359 1998 1 18 (Pubitemid 28515716)
43. P.J. McLaughlin, K. Winston, L. Swezey, A. Wisniecki, J. Aberman, D.J. Tardif, A.J. Betz, K. Ishiwari, A. Makriyannis, and J.D. Salamone The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats Behav. Pharmacol. 14 8 2003 583 588
44. E.S. Onaivi An endocannabinoid hypothesis of drug reward and drug addiction Ann. N. Y. Acad. Sci. 1139 2008 412 421
45. E.S. Onaivi, O. Carpio, H. Ishiguro, N. Schanz, G.R. Uhl, and R. Benno Behavioral effects of CB2 cannabinoid receptor activation and its influence on food and alcohol consumption Ann. N. Y. Acad. Sci. 1139 2008 426 433
46. E.S. Onaivi, H. Ishiguro, J.P. Gong, S. Patel, P.A. Meozzi, L. Myers, A. Perchuk, Z. Mora, P.A. Tagliaferro, E. Gardner, A. Brusco, B.E. Akinshola, Q.R. Liu, S.S. Chirwa, B. Hope, J. Lujilde, T. Inada, S. Iwasaki, D. Macharia, L. Teasenfitz, T. Arinami, and G.R. Uhl Functional expression of brain neuronal CB2 cannabinoid receptors are involved in the effects of drugs of abuse and in depression Ann. N. Y. Acad. Sci. 1139 2008 434 449
47. S.E. O'Sullivan, and D.A. Kendall Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease Immunobiology 215 8 2010 611 616
48. R.G. Pertwee, A.C. Howlett, M.E. Abood, S.P.H. Alexander, V. Di Marzo, M.R. Elphick, P.J. Greasley, H.S. Hansen, G. Kunos, K. Mackie, R. Mechoulam, and R.A. Ross International Union of Basics and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2 Pharmacol. Rev. 62 2010 588 631
49. S.M. Rawls, Z. Ding, and A. Cowan Role of TRPV1 and cannabinoid CB1 receptors in AM 404-evoked hypothermia in rats Pharmacol. Biochem. Behav. 83 2006 508 516 (Pubitemid 43817120)
50. C.J. Riebe, T.T. Lee, M.N. Hill, and B.B. Gorzalka Precipitated withdrawal counters the adverse effects of subchronic cannabinoid administration on male rat sexual behavior Neurosci. Lett. 472 2010 171 174
51. M. Rinaldi-Carmona, F. Barth, J. Millan, J.M. Derocq, P. Casellas, C. Congy, D. Oustric, M. Sarran, M. Bouaboula, B. Calandra, M. Portier, D. Shire, J.C. Brelière, and G.L. Le Fur SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor J. Pharmacol. Exp. Ther. 284 2 1988 644 650
52. R.J. Rodgers, P.M. Evans, and A. Murphy Anxiogenic profile of AM-251, a selective cannabinoid CB1 receptor antagonist, in plus-maze-naïve and plus-maze-experienced mice Behav. Pharmacol. 16 5-6 2005 405 413 (Pubitemid 41404812)
53. F. Rodríguez de Fonseca, I. Del Arco, J.L. Martín- Calderón, M.A. Gorriti, and M. Navarro Role of the endogenous cannabinoid system in the regulation of motor activity Neurobiol. Dis. 5 6 Pt B 1998 483 501 (Pubitemid 29075847)
54. T. Rubino, N. Realini, C. Castiglioni, C. Guidali, D. Viganó, E. Marras, S. Petrosino, G. Perletti, M. Maccarrone, V. Di Marzo, and D. Parolaro Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex Cereb. Cortex 18 6 2008 1292 1301 (Pubitemid 351769783)
55. J.R. Savinainen, T. Järvinen, K. Laine, and J.T. Laitinen Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB(1) receptor-dependent G-protein activation in rat cerebellar membranes Br. J. Pharmacol. 134 3 2001 664 672 (Pubitemid 32977912)
56. M. Scherma, L.V. Panlilio, P. Fadda, L. Fattore, I. Gamaleddin, B. Le Foll, Z. Justinová, E. Mikics, J. Haller, J. Medalie, J. Stroik, C. Barnes, S. Yasar, G. Tanda, D. Piomelli, W. Fratta, and S.R. Goldberg Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3′-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats J. Pharmacol. Exp. Ther. 327 2 2008 482 490
57. D.A. Scott, C.E. Wright, and J.A. Angus Evidence that CB-1 and CB-2 cannabinoid receptors mediate antinociception in neurophatic pain in the rat Pain 109 2004 124 131 (Pubitemid 38479778)
58. L.P. Shearman, K.M. Rosko, R. Fleischer, J. Wang, S. Xu, X.S. Tong, and B.A. Rocha Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice Behav. Pharmacol. 14 8 2003 573 582
59. M. Solinas, G. Tanda, Z. Justinova, C.E. Wertheim, S. Yasar, D. Piomelli, S.K. Vadivel, A. Makriyannis, and S.R. Goldberg The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport J. Pharmacol. Exp. Ther. 321 1 2007 370 380 (Pubitemid 46456957)
60. K. Starowicz, L. Cristino, and V. Di Marzo TRPV1 receptors in the central nervous system: potential for previously unforeseen therapeutic applications Curr. Pharm. Des. 14 1 2008 42 54 (Pubitemid 351266983)
61. N. Stella, P. Schweitzer, and D. Piomelli A second endogenous cannabinoid that modulates long-term potentiation Nature 388 1997 773 777
62. N. Stella Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas Glia 58 9 2010 1017 1030
63. T. Sugiura, S. Kishimoto, S. Oka, and M. Gokoh Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand Prog. Lipid Res. 45 2006 405 446
64. D. Thewke, N. Freeman-Anderson, T. Pickle, C. Netherland, and C. Chilton AM-251 and SR144528 are acyl CoA:cholesterol acyltransferase inhibitors Biochem. Biophys. Res. Commun. 381 2 2009 181 186
65. E. Tibiriça The multiple functions of the endocannabinoid system: a focus on the regulation of food intake Diabetol. Metab. Syndr. 21 2010 2 5
66. V. Trezza, and L.J. Vanderschuren Bidirectional cannabinoid modulation of social behavior in adolescent rats Psychopharmacology (Berl) 197 2 2008 217 227
67. N. Ueda, K. Tsuboi, T. Uyama, and T. Ohnishi Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol Biofactors 37 1 2011 1 7
68. A. Varga, J. Németh, Á. Szabó, J.J. McDougall, C. Zhang, K. Elekes, E. Pintér, J. Szolcsányi, and Z. Helyes Effects of the novel TRPV1 receptor antagonist SB366791 in vitro and in vivo in the rat Neurosci. Lett. 385 2005 137 142 (Pubitemid 40961650)
69. Z.X. Xi, J.G. Gilbert, X.Q. Peng, A.C. Pak, X. Li, and E.L. Gardner Cannabinoid CB1 receptor antagonist AM251 inhibits cocaine-primed relapse in rats: role of glutamate in the nucleus accumbens J. Neurosci. 26 33 2006 8531 8536 (Pubitemid 44316182)
70. Z.X. Xi, K. Spiller, A.C. Pak, J. Gilbert, C. Dillon, X. Li, X.Q. Peng, and E.L. Gardner Cannabinoid CB1 receptor antagonists attenuate cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats Neuropsychopharmacology 33 7 2008 1735 1745 (Pubitemid 351684714)
71. P.M. Zygmunt, J. Petersson, D.A. Andersson, H. Chuang, R.D. Sfrga, V. Di Marzo, D. Julius, and E.D. Högestätt Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide Nature 400 1999 452 457 (Pubitemid 29361798)